Opendata, web and dolomites


Improving Safety and comfort for kidney transplanted patients by enabling Accurate therapeutic drug monitoring through quantitative Capillary home Sampling

Total Cost €


EC-Contrib. €






 ISACS project word cloud

Explore the words cloud of the ISACS project. It provides you a very rough idea of what is the project "ISACS" about.

mobility    alleviate    transplant    expands    blood    life    launch    prepare    portable    lifelong    station    risk    perspective    medical    healthcare    tool    regular    innovative    market    demand    labor    measured    frequent    microsampling    accuracy    germany    sampling    proximity    windows    hospital    proposes    mail    levels    intends    partnership    attracted    improves    monitoring    ab    thereby    treatment    reducing    business    patient    create    feasibility    kidney    accurate    heavy    sent    gap    drugs    prevent    dessau    ed    prick    variables    device    transplantation    finger    refusal    source    quantitative    space    visits    rejection    centre    home    broad    plan    multispectral    volume    dialysis    consumes    concentration    organ    substantial    inconvenience    patients    quality    concentrations    filling    platform    sales    phlebotomy    delineated    tdm    immune    immunosuppressive    eliminates    burden    capacity    drug    capitainer    commercial    philosophy    laboratory    therapeutic   

Project "ISACS" data sheet

The following table provides information about the project.


Organization address
postcode: 112 20
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Sweden [SE]
 Project website
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-1
 Funding Scheme SME-1
 Starting year 2019
 Duration (year-month-day) from 2019-05-01   to  2019-10-31


Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    CAPITAINER AB SE (STOCKHOLM) coordinator 50˙000.00


 Project objective

Capitainer AB aims to develop a business plan for the broad-scale commercial launch of Capitainer-B – an innovative tool for quantitative blood microsampling. For kidney transplant patients, a new organ eliminates the need of frequent dialysis and improves the quality of life, but to prevent rejection of the new organ by the patient’s own immune system, lifelong treatment with immunosuppressive drugs is necessary. To ensure that the concentration of drugs remain within their therapeutic windows, drug levels are continuously measured through blood testing after transplantation: TDM - Therapeutic Drug Monitoring. Traditional phlebotomy at the hospital consumes substantial resources from the healthcare system and for patients, frequent visits to the hospital/test station is a source of inconvenience. As such, the development of an accurate “use-at-home” blood sampling tool that can alleviate this heavy burden is in great demand. Filling this market gap, Capitainer AB proposes Capitainer-B - a portable, cost effective and easy-to-use microsampling system which enables the patient to take a blood sample at home through a finger prick. The sample can be sent via regular mail to the laboratory for analysis. Our design philosophy was to create a reliable and easy to use tool for monitoring drug concentrations in blood, thereby reducing the risk of organ refusal. From the business perspective, Capitainer-B expands into the market space delineated by the variables of volume accuracy, patient proximity, mobility and low cost. The device has already attracted attention of one EU-based medical centre in Germany (Labor Dessau GmbH) which resulted in a research partnership and low scale sales. In this Phase 1 Project, Capitainer AB intends to prepare a multispectral market feasibility assessment for Capitainer-B. Furthermore, we plan to study the market capacity for the further Capitainer-B-type devices, aiming at providing a comprehensive blood testing platform.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ISACS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email ( and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "ISACS" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

COPI (2020)

Carbon Offset Plug-in

Read More  

Cortx (2019)

Intelligent debt recovery platform.

Read More  

Magnesys (2019)

Efficient filtering of metallic impurities in food processing

Read More